Evidence map›Paper›PMID 42421315›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

Distinct YY dinucleotide periodicity in adeno-associated virus DNA.

Conradin Baumgartl, Jonas Becker, Lena Naber, Man Xu, Emma Gerstmann, Julie Garcia Gonzalez-Calero, Joyce Suppacher, Sebastian Heß, Felix Bubeck, Dirk Grimm

Abstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Conradin BaumgartlDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Jonas BeckerDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Lena NaberDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Man XuDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Emma GerstmannDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Julie Garcia Gonzalez-CaleroAbbVie Deutschland GmbH & Co. KG, 67061 Ludwigshafen, Germany.
Joyce SuppacherDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Sebastian HeßDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Felix BubeckDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany.
Dirk GrimmDepartment of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120 Heidelberg, Germany; German Center for Infection Research (DZIF) and German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, 69120 Heidelberg, Germany; Faculty of Engineering Sciences, Heidelberg University, 69120 Heidelberg, Germany. Electronic address: dirk.grimm@bioquant.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dinucleotide periodicity is a hallmark of genome organization, yet its role in single-stranded (ss)DNA viruses remains poorly understood. Here, we systematically analyzed dinucleotide spacing patterns in adeno-associated virus (AAV) genomes and other viruses. Across 13 primate AAV serotypes, we identified a pronounced and highly conserved ∼15-bp periodicity specific to pyrimidine-pyrimidine (YY) dinucleotides and their reverse complements (RR). Comparative analyses across >25,000 viral sequences demonstrate that this 15-bp YY/RR periodicity is unique to the genus Dependoparvovirus and absent from other ssDNA viruses, satellite viruses, and helper viruses, which predominantly exhibit canonical ∼10- to 11-bp periodicities. Upon disruption of the YY/RR pattern using DNA family shuffling of AAV capsid genes, and subsequent iterative selection for viral production or cell entry, we found that the pattern is under positive selection. Selected sequences display increased periodicity alongside reduced sequence diversity, supporting a functional role for this genomic feature. Finally, engineered recombinant AAV genomes containing YY periodic motifs exhibit enhanced production and, for some designs, improved transduction efficiency, demonstrating that YY periodicity can modulate viral replication and infectivity. Our findings uncover a unique DNA-encoded signal in dependoparvoviruses that contributes to AAV fitness, expands our knowledge of virus biology, and has implications for vector engineering.

Indexed as

DependovirusDNA, ViralGenome, ViralAnimalsGenetic VectorsHumansVirus ReplicationDNA, ViralAAVadeno-associated virusgenomeperiodicityvectors

Identifiers

PMID42421315
PMCPMC13555545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.